Cingulate CING
NASDAQ CING
$4.59 +0.14 (+3.03%)
As of: Nov 10, 2026 · 2:07 PM EST

Cingulate (CING) Change in Receivables (2021 - 2024)

Updated

Cingulate (CING) posted Change in Receivables of -$18,312 for FY2025, compared with $11,703 in FY2024.

Analysis

Cingulate (CING) Change in Receivables (2021 - 2024) Analysis & Trends

Since FY2021, Cingulate has reported Change in Receivables for 5 years.

  • Annual Change in Receivables has run from a low of -$455,816 in FY2022 to a high of $538,476 in FY2021 over five years.
  • Business Quant data shows CING's Change in Receivables at $11,703 in FY2024, -$219,810 in FY2023, -$455,816 in FY2022 and $538,476 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -188.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -312.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -52.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Cingulate 63.03 Mn -8.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -12,375.00
Dec 31, 2023 8,786.00
Sep 30, 2023 -29,634.00
Jun 30, 2023 3,517.00
Mar 31, 2023 -202,479.00
Dec 31, 2022 187,083.00
Sep 30, 2022 -92,764.00
Jun 30, 2022 -511,258.00
Mar 31, 2022 -38,877.00
Dec 31, 2021 333,186.00
Sep 30, 2021 76,762.00
Jun 30, 2021 74,400.00
Mar 31, 2021 54,128.00
API Access

Cingulate Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=CING&period=max&api_key=YOUR_API_KEY